Veracyte, Inc. (VCYT) earnings
VCYT earnings moved a median of -0.60% by the close. Quarterly and annual VCYT reports and results, each read against the price at its own news timestamp. Back to the VCYT overview →
30 measured VCYT earnings events.
Where these VCYT earnings landedvs 30 measured VCYT earnings reactions
| Middle 50% of VCYT earnings reactions | -3.82% to +3.53% |
|---|---|
| Median reaction (to close) | -0.60% |
| Measured reactions | 30 |
Point-in-time · zero look-ahead
Half of the 30 VCYT earnings events with a measured close landed between -3.82% and +3.53%; 43% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q VERACYTE, INC. For: Jun 30 | SEC filing · Form 10-Q | -2.46% | -3.26% | |
| Veracyte Announces Second Quarter 2026 Financial Results | Press release | -4.00% | -5.37% | |
| Veracyte to Release Second Quarter 2026 Financial Results on July 30, 2026 | Press release | -1.29% | -3.60% | |
| Form 10-Q VERACYTE, INC. For: Mar 31 | SEC filing · Form 10-Q | -2.35% | +8.25% | |
| Veracyte Announces First Quarter 2026 Financial Results | Press release | -2.35% | +8.25% | |
| Veracyte to Release First Quarter 2026 Financial Results on May 5, 2026 | Press release | +0.57% | -0.76% | |
| Form 10-K VERACYTE, INC. For: Dec 31 | SEC filing · Form 10-K | +1.26% | -3.53% | |
| Form 10-Q VERACYTE, INC. For: Sep 30 | SEC filing · Form 10-Q | +7.69% | +15.10% | |
| Veracyte Announces Third Quarter 2025 Financial Results | Press release | +7.69% | +15.10% | |
| Veracyte to Release Third Quarter 2025 Financial Results on November 4, 2025 | Press release | +0.65% | +1.56% | |
| Form 10-Q VERACYTE, INC. For: Jun 30 | SEC filing · Form 10-Q | +0.38% | -1.44% | |
| Veracyte Announces Second Quarter 2025 Financial Results | Press release | +3.58% | +6.46% | |
| Veracyte to Release Second Quarter 2025 Financial Results on August 6, 2025 | Press release | -1.14% | -4.70% | |
| Form 10-Q VERACYTE, INC. For: Mar 31 | SEC filing · Form 10-Q | -6.21% | +3.62% | |
| Veracyte Announces First Quarter 2025 Financial Results | Press release | -6.21% | +3.62% | |
| Veracyte to Release First Quarter 2025 Financial Results on May 7, 2025 | Press release | -0.10% | -0.45% | |
| Form 10-K VERACYTE, INC. For: Dec 31 | SEC filing · Form 10-K | +1.35% | +4.38% | |
| Form 10-Q VERACYTE, INC. For: Sep 30 | SEC filing · Form 10-Q | -1.98% | -5.95% | |
| Veracyte Announces Third Quarter 2024 Financial Results | Press release | -1.98% | -5.95% | |
| Veracyte to Release Third Quarter 2024 Financial Results on November 6, 2024 | Press release | -0.55% | -1.35% | |
| Form 10-Q VERACYTE, INC. For: Jun 30 | SEC filing · Form 10-Q | -0.15% | +3.24% | |
| Veracyte Announces Second Quarter 2024 Financial Results | Press release | -0.15% | +3.24% | |
| Veracyte to Release Second Quarter 2024 Financial Results on August 6, 2024 | Press release | -0.25% | -3.90% | |
| Form 10-Q VERACYTE, INC. For: Mar 31 | SEC filing · Form 10-Q | +0.10% | +2.54% | |
| Veracyte Announces First Quarter 2024 Financial Results | Press release | -1.90% | -6.89% | |
| Veracyte to Release First Quarter 2024 Financial Results on May 7, 2024 | Press release | -0.05% | -0.25% | |
| Form 10-K VERACYTE, INC. For: Dec 31 | SEC filing · Form 10-K | -1.61% | -2.93% | |
| Form 10-Q VERACYTE, INC. For: Sep 30 | SEC filing · Form 10-Q | -4.91% | -7.18% | |
| Veracyte Announces Third Quarter 2023 Financial Results | Press release | -4.91% | -7.18% | |
| Veracyte to Release Third Quarter 2023 Financial Results on November 7, 2023 | Press release | +1.33% | +2.43% |
Keep exploring
More VCYT: analyst actions → · SEC filings → · VCYT overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| TRULIEVE CANNABIS CORP (TCNNF) | 429 | +0.41% | 58% |
| Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares (KNSA) | 427 | -0.21% | 39% |
| Moleculin Biotech, Inc. (MBRX) | 426 | -0.21% | 43% |
| Summit Therapeutics Inc. (SMMT) | 426 | +0.03% | 50% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.